Jan 8, 2015
114th Congress, 2015–2017
Enacted — Signed by the President on Oct 7, 2015
This bill was enacted after being signed by the President on October 7, 2015.
Senior Senator from Oregon
Read Text »
Last Updated: Sep 30, 2015
Length: 1 pages
About the bill
A bill to permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.
There are 30 million Americans living with what S. 139 calls “rare diseases or conditions.” It is difficult enough facing such disorders, but it can be even more difficult finding those willing to participate in clinical trials to provide information, treat and perhaps even cure these conditions. The definition of “rare disease” in the U.S. is “any disease or ...
This is the first step in the legislative process.
The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.
Enacted — Signed by the President
The President signed the bill and it became law.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 139 — 114th Congress: Ensuring Access to Clinical Trials Act of 2015. Retrieved from https://www.govtrack.us/congress/bills/114/s139
“S. 139 — 114th Congress: Ensuring Access to Clinical Trials Act of 2015.” www.GovTrack.us. 2015. September 26, 2016 <https://www.govtrack.us/congress/bills/114/s139>
|title=S. 139 (114th)
|accessdate=September 26, 2016
|author=114th Congress (2015)
|date=January 8, 2015
|quote=Ensuring Access to Clinical Trials Act of 2015